nhc20230504_8k.htm
false 0001047335 0001047335 2023-05-04 2023-05-04
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 5, 2023 (May 4, 2023)
 
 
NATIONAL HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
 
 
Delaware
(State or other jurisdiction of
incorporation)
001-13489
(Commission File Number)
52-2057472
(I.R.S. Employer Identification
No.)
100 E. Vine Street
Murfreesboro, Tennessee
(Address of Principal Executive
Offices)
  
37130
(Zip Code)
 
Registrant’s telephone number, including area code: (615) 890-2020
 
Not Applicable
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Exchange Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.01 par value
NHC
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
ITEM 2.02.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION
 
National HealthCare Corporation (“NHC”) issued a press release on May 5, 2023, announcing its March 31, 2023 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
 
 
 
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.
 
(d)
Exhibits.
 
Exhibit No.
Description of Exhibit
99.1
Copy of press release issued on May 5, 2023 by National HealthCare Corporation announcing March 31, 2023 earnings.
   
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:         May 5, 2023
 
 
NATIONAL HEALTHCARE CORPORATION
  
       
       
 
By:
/s/ 
Brian F. Kidd
  
 
Name:
Title:
Brian F. Kidd
Senior VP/Controller
Principal Accounting Officer